Swipe to discover more

• BioFire Defense partners with BARDA to accelerate development of the SPECIFIC REVEAL™ Rapid AST System

  BioFire Defense, LLC, has received a contract from the BARDA (Biomedical Advanced Research and Development Authority) to accelerate development of the Specific Diagnostics SPECIFIC REVEAL™ Rapid AST System that can deliver phenotypic results in an average of five and a half hours from positive blood cultures.

  Read more
  

• Burn Patients Often Have Higher Rates of Multidrug-Resistant Infections—But There are Ways to Help

  Patients who are admitted to the hospital with large burn injuries are at especially high risk for developing hospital-associated infections (HAIs), and the longer a patient stays in the hospital, the more likely they are to acquire a resistant infection.

  Read more
  

• March 8 – and every day –, let’s #EmbraceEquity

  At bioMérieux, we support the inclusion, well-being and development of our team members and are committed to creating a culture of belonging and acceptance where all feel respected, supported and included.

  Read more